title: Sean Ekins on Regulating AI Drug Discovery
original_url: '"https://zencastr.com/z/28OZcOzu"'
date_published: '2023-01-12'
host:
  name: Koss Dokker
  affiliation: Future of Life Institute
guests:
- name: Sean Ekins
  affiliation: Independent Researcher
  title: Pharmacologist and Expert in Computational Toxicology
  bio: Sean Ekins is a pharmacologist with extensive experience in computational toxicology
    and drug discovery.
  expertise_areas:
  - Computational Toxicology
  - Artificial Intelligence in Drug Discovery
  - Pharmaceutical Research
synopsis: In this episode, Koss Dokker continues his conversation with Sean Ekins
  about the ethical implications and regulatory landscape surrounding the use of artificial
  intelligence in drug discovery. They discuss the need for guidelines and the responsibility
  of scientists in addressing AI risks.
key_topics:
- AI in Drug Discovery
- Ethical Guidelines and Responsibilities
- Impact of AI on Pharmaceutical Industry
- Regulatory Landscape for AI Technologies
tags:
- AI
- Drug Discovery
- Ethics
- Pharmaceuticals
key_points:
- There is a critical need for awareness in the pharmaceutical industry regarding
  AI risks.
- Sean Ekins emphasizes the importance of ethical guidelines and regulations in AI
  applications.
- The conversation highlights the potential for both positive and negative outcomes
  of AI in drug discovery.
segments:
- title: Role of Scientists in AI Ethics
  summary: Discussion on the necessity for scientists to engage in the ethical and
    policy conversations surrounding AI.
  key_quotes:
  - quote: Our naivety is a liability in this case and that we need to start adopting
      something.
    speaker: Sean Ekins
    context: Referring to the responsibility of scientists in addressing AI risks.
- title: AI Ethics Policies and Guidelines
  summary: Ekins discusses the current state of AI ethics guidelines and the need
    for the pharmaceutical industry to adopt them.
  key_quotes:
  - quote: '"There''s definitely going to be a challenge there of educating people."'
    speaker: Sean Ekins
    context: On the difficulty of communicating the need for AI guidelines to scientists.
- title: Positive Applications of AI in Medicine
  summary: Exploration of the beneficial uses of AI to create therapeutic molecules.
  key_quotes:
  - quote: We could design molecules that would treat opioid use disorder.
    speaker: Sean Ekins
    context: Highlighting the potential for AI to help in drug development.
websites_referenced:
- url: '"https://futureoflife.org"'
  name: Future of Life Institute
  context: Organization focusing on mitigating existential risks from advanced technologies.
  access_date: '2023-01-12'
tools_mentioned: []
research_papers:
- title: ''
  authors: []
  year: null
  url: ''
  key_findings: ''
  context: ''
books_referenced: []
organizations:
  academic_institutions: []
  companies: []
  non_profits:
  - name: Future of Life Institute
    focus_area: Ethical considerations of AI and emerging technologies
    context: Focus on mitigating risks associated with advanced technologies.
  government_agencies: []
notable_people:
  academics: []
  industry_leaders: []
  policy_makers: []
projects_mentioned: []
events:
  historical: []
  upcoming: []
keywords:
- Artificial Intelligence
- Drug Regulation
- Pharmaceutical Ethics
categories:
- Science
- Technology
- Ethics
intended_audience: Researchers, policymakers, and industry professionals
expertise_level: Intermediate
recommended_reading: []
action_items:
- Increase awareness and education within the pharmaceutical industry on AI ethics.
controversial_topics:
- topic: The Risks of AI in Drug Discovery
  different_viewpoints:
  - perspective: AI could revolutionize drug discovery.
    proponents: Proponents of AI technology in pharmaceuticals.
    key_arguments: Promise of accelerated drug development and innovation.
  - perspective: AI poses significant ethical and safety risks.
    proponents: Ethicists and cautious scientists.
    key_arguments: Need for stringent regulations to avoid misuse.
